SA

Sara Alexander

Director Director DIN 02389506
DIN 02389506 First appointment Jan 1996 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jan 1996
Shareholding value Locked Premium profile

About Sara Alexander

Data last updated:

Sara Alexander has 30 years in corporate governance. Formerly with 1 company, such as Sangros Drugchem Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02389506
Primary Designation Director
First Appointment 11 Jan 1996
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Sangros Drugchem Private Limited U24231KL1996PTC009906
Director11 Jan 19961996Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sangros Drugchem Private Limited
Premium access

Shareholding and investment profile for Sara Alexander

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sara Alexander

Sara Alexander has 30 years in corporate governance. Formerly with 1 company, such as Sangros Drugchem Private Limited. Engaged in General Business. Contributes to corporate operations.

Sara Alexander is associated with 0 companies as a director.

Sara Alexander has expertise in General Business.

Sara Alexander has 30 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available